IIM patients often have one of various myositis-specific autoantibodies (MSAs), such as anti-aminoacyl tRNA synthetases (ARS) and anti-melanoma differentiation-associated gene 5 (MDA5) autoantibodies [3, 4]. This evidence concerns the gene IFIH1 and acquired idiopathic inflammatory myopathy.